Small-cap newsflow was dominated by consolidation and legal wrangling in resources, alongside a run of third-quarter trading updates that showed UK retail and diagnostics names holding up better than headline macro gloom might suggest. Gulf Keystone's tie-up with ShaMaran Petroleum headlined a busy corporate action day, while Arkadian Strategic Metals combined an asset disposal with a Swedish lawsuit, and Wickes, Quantum Helium and IXICO all reported accelerating growth.
Arkadian agrees Horse Hill exit, sues partner over Finnsbo earn-in
Arkadian Strategic Metals (AIM:AKN), the gold and strategic metals explorer, is stepping back from oil exploration and digging in for a courtroom fight over one of its gold assets. The company has agreed to sell its entire 18.1% stake in Horse Hill Developments, owner of the Horse Hill oil project in Surrey, to energy B, drawing a line under an investment carried at nil on its books. Shares rose 12.5% to 0.009p as the twin announcements landed.
Under the terms, Arkadian will receive £137,386 in cash for shares representing an effective 11.765% interest in licence PEDL137, with £13,739 already paid non-refundably and the £123,647 balance due on completion. It will also receive 400,000 warrants exercisable at 12p over three years in exchange for releasing its shareholder loan to Horse Hill Developments. Completion is conditional on energy B simultaneously completing its acquisition of the majority Horse Hill interest from UK Energy and on North Sea Transition Authority approval, with that application submitted on 30 September. Separately, Arkadian has filed proceedings in the Stockholm District Court against McKnight Resources AB over the Finnsbo gold exploration project in Sweden, arguing it had earned a 25% interest by meeting agreed Stage 1 exploration spend before McKnight purportedly terminated those rights in November 2025, while Arkadian was still drilling the programme's third and final hole.
"The Board considers McKnight's actions in these circumstances, and its continuing refusal to recognise and give effect to," said the company in its statement on the Finnsbo dispute.
The Horse Hill disposal tidies up Arkadian's balance sheet and converts a dormant, nil-value holding into cash plus optionality via the warrants, letting management focus capital and attention on its metals exploration pipeline. The Finnsbo litigation is the more consequential thread for the investment case: if Arkadian prevails in Stockholm, it recovers a quarter interest in a gold project it says it had already earned through drilling and permitting work, but litigation introduces cost, delay and uncertainty into an asset that was previously a clean growth option, and the market's sharp reaction suggests investors are pricing both the clean exit and the unresolved overhang.
Gulf Keystone agrees merger with ShaMaran Petroleum
Gulf Keystone Petroleum (LSE:GKP) has agreed to merge with ShaMaran Petroleum, a deal the pair bill as creating a leading independent oil producer across the Kurdistan Region of Iraq and Federal Iraq. The announcement came alongside an operational update confirming the Shaikan field is running at full well capacity of roughly 45,000 barrels of oil per day, shares fell 9.53% to 203.55p despite the strategic rationale, reflecting investor caution over deal terms and a volatile production backdrop.
Shaikan output has been anything but steady through 2026, with the field shut in twice on security grounds, first between 28 February and 23 June and again from 19 July to 15 August, before climbing back to full capacity. Gulf Keystone also disclosed that a maiden top-up cargo was recently lifted after Iraq's State Oil Marketing Organisation allocated extra barrels to reconcile part of its fourth-quarter 2025 export sales against international prices, a sign the long-running reconciliation process with Baghdad is moving forward.
The merger consolidates two of Kurdistan's most prominent independent producers at a moment when security disruptions and payment reconciliation have made standalone operation increasingly fraught; scale and a broader footprint across both Kurdistan and Federal Iraq should improve bargaining power with Baghdad and reduce the earnings volatility that has plagued both companies individually, even if the market's initial verdict on the share price was unforgiving.
Quantum Helium nine-month oil revenue tops full-year 2025
Quantum Helium (AIM:QHE) told investors gross oil revenue from its Sagebrush Project for the first nine months of 2026 has already surpassed the whole of 2025's total, with a full quarter still to come. Shares in the helium and gas junior, which is developing extraction projects in Saskatchewan and Colorado, rose 5.4% to 1.475p on the update.
Nine-month project oil revenue reached US$500,765 against US$408,532 for all of 2025, a roughly 23% increase, with Quantum's 90% working interest share amounting to US$450,688. Third-quarter revenue alone came to US$184,502, with Quantum's share at US$166,052, on gross production of 2,630 barrels at an average realised price of US$71.28 a barrel; nine-month gross production totalled 7,771 barrels across three quarters of roughly 2,500-2,700 barrels each.
"Our oil production in the first 9 months of Calendar 2026 continues to deliver an important revenue stream for Quantum, and it is particularly pleasing that we have already exceeded the revenue generated during the whole of calendar 2025, with another three months of production still to come," said Howard McLaughlin, chief executive. The steady quarter-on-quarter consistency in production volumes, alongside a firm realised price, underpins the case that Sagebrush is now a reliable, growing cash generator rather than a speculative early-stage asset.
Ondine Biomedical raises £10m as trading resumes on AIM
Ondine Biomedical (AIM:OBI) has completed a £10m fundraise, with shares resuming trading on AIM up 3.47% at 10.233p once dealings restarted. The raise gives the photodisinfection therapeutics developer fresh capital to advance its pipeline following the suspension linked to the financing process.
The cash injection strengthens the balance sheet at a point when the company needs runway to progress commercial and clinical milestones, and the resumption of trading removes the uncertainty overhang that typically accompanies a suspended line.
IXICO upgrades revenue growth again as orders accelerate
IXICO (AIM:IXI) raised its revenue growth guidance for a second time this year, with shares trading at 7.75p as the imaging and data analytics specialist for clinical trials pointed to accelerating order intake. The upgrade marks a consistent pattern of outperformance against prior expectations through the year.
Repeated upgrades signal that demand from pharmaceutical and biotech clients for IXICO's neuroimaging trial services is building momentum rather than plateauing, reinforcing confidence in the medium-term growth trajectory.
Gear4music revenue growth holds, warehouse costs weigh
Gear4music (AIM:G4M) shares traded at 235.0p as the musical instruments retailer reported revenue growth holding steady, though rising warehouse costs weighed on the margin outlook. The update points to resilient top-line demand even as cost pressures build beneath it.
The divergence between steady sales growth and squeezed logistics economics will keep the focus on cost control as the key swing factor for profitability into the next trading period.
Trifast narrows revenue decline as margins keep improving
Trifast (LSE:TRI) shares were broadly flat at 85.2p, down 0.47%, as the fastenings group reported a narrowing revenue decline alongside continued margin improvement. The update suggests the worst of the top-line pressure may be easing even as profitability metrics keep trending in the right direction.
Margin progress against a softer revenue backdrop points to effective cost discipline, giving the business a firmer footing if end-market demand stabilises further.
GBG confirms FY27 outlook despite Americas Identity drag
GBG reaffirmed its FY27 outlook even as its Americas Identity division continued to act as a drag on performance, with shares in GB Group (LSE:GBG) falling 4.81% to 150.4p. The identity verification specialist is holding the line on guidance despite regional softness.
Maintaining full-year guidance against a weak Americas segment suggests other parts of the business are compensating, though the market's negative reaction indicates lingering concern over how quickly that division can turn around.
Sabre Insurance Group reiterates full-year profit guidance
Sabre Insurance Group (LSE:SBRE) reiterated its full-year profit guidance, with shares edging up 1.23% to 181.2p. The reaffirmation offers reassurance that the motor insurer's underwriting performance remains on track.
Consistency in guidance from a specialist underwriter helps underpin confidence in the reliability of its pricing discipline through the current claims environment.
Shearwater's Brookcourt wins £1.7m government threat intelligence deal
Shearwater Group (AIM:SWG) saw its Brookcourt Solutions subsidiary secure a £1.7m contract to supply threat intelligence services to a government client, with shares up 0.72% to 69.5p. The win adds to the cybersecurity group's public sector order book.
A government contract of this size provides a visible revenue contribution and strengthens Shearwater's credentials in a security niche where public sector trust is a key sales driver.
Kenmare reacts to Mozambique media reports on Moma licence renewal
Kenmare Resources (LSE:KMR) issued a response to Mozambican media reports concerning the renewal of the mining licence at its Moma titanium minerals operation, with shares falling 3.28% to 221.5p. The statement aims to clarify the company's position amid external reporting on the licence process.
Licence renewal uncertainty at a single-asset producer's core operation is a material overhang, and the share price reaction reflects investor sensitivity to any ambiguity around Moma's long-term regulatory standing.
Gulf Marine Services revenue rises as day rates offset lower utilisation
Gulf Marine Services (LSE:GMS) reported rising revenue as higher day rates more than offset lower utilisation across its fleet, with shares up 1.73% at 18.8p. The offshore support vessel operator is capturing pricing gains even as deployment levels soften.
Pricing power outweighing utilisation softness is a favourable mix for margins, suggesting the charter market remains tight enough to support rates despite any near-term scheduling gaps.
Optima Health revenue jumps 60% on PAM Healthcare integration
Optima Health (AIM:OPT) reported a 60% jump in revenue following the integration of PAM Healthcare, with shares slightly lower, down 1.02% at 243.5p. The occupational health provider's acquisition-driven growth marks a step-change in scale.
A 60% revenue uplift from integration demonstrates the deal's immediate top-line impact, with the modest share price dip likely reflecting focus on how smoothly the combined cost base and service delivery are bedding in.